1. Home
  2. CAAP vs ADMA Comparison

CAAP vs ADMA Comparison

Compare CAAP & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corporacion America Airports SA

CAAP

Corporacion America Airports SA

HOLD

Current Price

$26.04

Market Cap

4.2B

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$19.78

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAAP
ADMA
Founded
1998
2004
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.1B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CAAP
ADMA
Price
$26.04
$19.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$24.60
$28.50
AVG Volume (30 Days)
176.7K
2.9M
Earning Date
11-24-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
205.35
EPS
1.09
0.86
Revenue
$1,872,934,000.00
$488,559,000.00
Revenue This Year
$3.24
$22.19
Revenue Next Year
$9.46
$24.33
P/E Ratio
$23.88
$23.11
Revenue Growth
25.19
27.63
52 Week Low
$15.01
$13.50
52 Week High
$26.97
$25.67

Technical Indicators

Market Signals
Indicator
CAAP
ADMA
Relative Strength Index (RSI) 69.79 66.02
Support Level $25.23 $19.13
Resistance Level $26.27 $20.22
Average True Range (ATR) 0.91 0.73
MACD -0.03 0.05
Stochastic Oscillator 78.75 79.44

Price Performance

Historical Comparison
CAAP
ADMA

About CAAP Corporacion America Airports SA

Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: